Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H17N3O3.BrH |
Molecular Weight | 368.226 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Br.COC1=CC=C(C=C1)C2=NN(CCCC(O)=O)C(=N)C=C2
InChI
InChIKey=GFZHNFOGCMEYTA-UHFFFAOYSA-N
InChI=1S/C15H17N3O3.BrH/c1-21-12-6-4-11(5-7-12)13-8-9-14(16)18(17-13)10-2-3-15(19)20;/h4-9,16H,2-3,10H2,1H3,(H,19,20);1H
Molecular Formula | BrH |
Molecular Weight | 80.912 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C15H17N3O3 |
Molecular Weight | 287.3138 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/8987785
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8987785
Gabazine (SR-95531) is a selective GABAA receptors antagonist, which does not have any role in medicine, but is used in scientific experiments as the allosteric inhibitor of channel opening for the GABAA receptor.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093872 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17419756 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Sprouting of mossy fibers and presynaptic inhibition by group II metabotropic glutamate receptors in pilocarpine-treated rat hippocampal slice cultures. | 2005 |
|
Presynaptic GABAA receptors facilitate spontaneous glutamate release from presynaptic terminals on mechanically dissociated rat CA3 pyramidal neurons. | 2006 |
|
Agonist-, antagonist-, and benzodiazepine-induced structural changes in the alpha1 Met113-Leu132 region of the GABAA receptor. | 2007 Feb |
|
GluK2-mediated excitability within the superficial layers of the entorhinal cortex. | 2009 |
|
Novel mGluR- and CB1R-independent suppression of GABA release caused by a contaminant of the group I metabotropic glutamate receptor agonist, DHPG. | 2009 Jul 1 |
|
An approach for reliably investigating hippocampal sharp wave-ripples in vitro. | 2009 Sep 7 |
|
Dopamine inhibition of glycine release in the rat trigeminal nucleus pars caudalis: possible involvement of trace amine receptors. | 2010 Sep |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16420421
Neonatal and 21-day-old (P21) rats: P3 rat pups were anaesthetized and a syringe containing 0.5 μl of 0.9 % saline with 2.2 μCi of 3[H]Gabazine was inserted intrathecally. The compound was injected and 10min post injection the animals were terminally anaesthetized with sodium pentobarbitone. Injections of 3H-gabazine in the L4-L5 region at P3 confirmed that gabazine binding was restricted to the lumbar spinal cord. The effects of spinalization were consistent with gabazine facilitation of ventral root potentials observed in isolated neonatal spinal cord.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11850512
Gabazine totally blocked evoked inhibitory postsynaptic currents (IPSCs) in CA3 pyramidal cells. The application of guanidinoethanesulfonic acid, an uptake inhibitor of beta-alanine and taurine, induced strychnine-sensitive chloride current in the presence of gabazine. To determine whether glycine receptors, which are expressed most strongly on CA3 pyramidal cells, are involved in synaptic transmission, it was characterized the pharmacological profile of the receptors mediating IPSCs evoked by brief extracellular stimulation (100 μs, single current pulse up to 30 μA) in the stratum radiatum of the CA3 region in the presence of CNQX (40 μm), CPP (40 μm) and CGP 62349 (5 μm). First, the sensitivity of the IPSC to GABAA receptor blockade by gabazine was tested. Evoked IPSCs and responses to GABA puffs were alternately induced. The degree of GABAA receptor blockade was monitored by examining the effect of gabazine on responses induced by GABA puffs, whose peak amplitudes were adjusted to match those of the alternately evoked IPSCs. Bath application of gabazine (10 μm) completely blocked the IPSC and inhibited the GABA-induced currents by 98.7 ± 0.3 % (n = 7). Application of gabazine also abolished spontaneous IPSCs. The incomplete blockade of responses to exogenous GABA by the competitive antagonist gabazine probably reflects the prolonged presence of GABA resulting from the puff applications, which may saturate GABA transporters, since even with the addition of gabazine to the GABA application pipette, GABA-induced currents could not be blocked completely.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:05:07 GMT 2023
by
admin
on
Sat Dec 16 08:05:07 GMT 2023
|
Record UNII |
99460MG420
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
104104-50-9
Created by
admin on Sat Dec 16 08:05:07 GMT 2023 , Edited by admin on Sat Dec 16 08:05:07 GMT 2023
|
PRIMARY | |||
|
Gabazine
Created by
admin on Sat Dec 16 08:05:07 GMT 2023 , Edited by admin on Sat Dec 16 08:05:07 GMT 2023
|
PRIMARY | |||
|
107895
Created by
admin on Sat Dec 16 08:05:07 GMT 2023 , Edited by admin on Sat Dec 16 08:05:07 GMT 2023
|
PRIMARY | |||
|
DTXSID40908798
Created by
admin on Sat Dec 16 08:05:07 GMT 2023 , Edited by admin on Sat Dec 16 08:05:07 GMT 2023
|
PRIMARY | |||
|
99460MG420
Created by
admin on Sat Dec 16 08:05:07 GMT 2023 , Edited by admin on Sat Dec 16 08:05:07 GMT 2023
|
PRIMARY | |||
|
300000014603
Created by
admin on Sat Dec 16 08:05:07 GMT 2023 , Edited by admin on Sat Dec 16 08:05:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |